JPMorgan Chase - The bank edged up after saying it would cut 3,000 more jobs than previously anticipated in its retail banking unit.
Avanir Pharmaceuticals - The drug developer declined after saying the Food and Drug Administration had raised concerns about its migraine treatment.
Allergan - The Botox maker fell after its biggest shareholder urged the company in a letter to give Valeant Pharmaceuticals a shot at buying it.
Agios Pharmaceuticals - The biopharmaceutical company slid after reporting weaker-than-expected third-quarter earnings.
Transocean - The offshore driller slipped after saying it would incur more than $2.7 billion in charges due to reduced demand for its rigs.
DaVita Healthcare Partners - The supplier of kidney dialysis fell after posting weaker-than-expected third-quarter results.
Medivation - The developer of a cancer drug rose after reporting a better-than-expected third-quarter profit.
Freshpet - The maker of healthy food for dogs and cats soared in its trading debut.
Fastenal -The maker of industrial fasteners dropped after saying its chief executive was stepping down.
(See CNBC's Market Insider Blog)
Questions? Comments? Email us at firstname.lastname@example.org